Pharmaceutical

FDA approves AbbVie’s VYALEV for advanced Parkinson’s treatment

The US FDA has approved AbbVie's VYALEV to treat motor fluctuations in adults with advanced Parkinson's disease (PD).

Oct 20, 2024 - 04:00
FDA approves AbbVie’s VYALEV for advanced Parkinson’s treatment
The US FDA has approved AbbVie's VYALEV to treat motor fluctuations in adults with advanced Parkinson's disease (PD).
Read the original article

Tags:

Previous Article

US Elections: how healthcare could look under a Harris or Trump administration

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: An inside look at PIPEs, the financing trend that has biotech abuzz

STAT+: An inside look at PIPEs, the financing trend tha...

Feb 29, 2024

STAT+: What past blockbusters can tell us about future of Wegovy and other weight loss medicines

STAT+: What past blockbusters can tell us about future ...

Aug 25, 2023

Sanofi and Orano Med link for radioligand therapy development

Sanofi and Orano Med link for radioligand therapy devel...

Oct 20, 2024